Coverage
-
March 22, 2021
A Florida federal judge has tossed a proposed shareholders' class action against nerve repair product manufacturer Axogen Inc. for a second time, but noted in his order that investors did not seek leave to further amend their complaint because of their stated intent to appeal the case as argued.
6 other articles on this case.
View all »